Evidence map›Paper›PMID 35604166›Full record

ArticleJournal of visualized experiments : JoVE2022

Ex Vivo Organoid Model of Adenovirus-Cre Mediated Gene Deletions in Mouse Urothelial Cells.

Dongbo Xu, Li Wang, Kyle Wieczorek, Yanqing Wang, Xiaojing Zhang, David W Goodrich, Qiang Li

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dongbo XuDepartment of Urology, Roswell Park Comprehensive Cancer Center.
Li WangDepartment of Urology, Roswell Park Comprehensive Cancer Center.
Kyle WieczorekDepartment of Urology, Roswell Park Comprehensive Cancer Center.
Yanqing WangDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center.
Xiaojing ZhangDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center.
David W GoodrichDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center.
Qiang LiDepartment of Urology, Roswell Park Comprehensive Cancer Center; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center; Qiang.Li@RoswellPark.org.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI CANDACE S JOHNSON · 1985 to 2026
$116.6M
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancerR01CA234162 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI GOODRICH, DAVID W. · 2019 to 2024
$3.0M
Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancerR01CA207757 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI ELLIS, LEIGH, GOODRICH, DAVID W. · 2016 to 2020
$2.8M
Therapeutic implication of RB1 loss in bladder cancerK08CA252161 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI LI, QIANG · 2021 to 2025
$1.4M
NCI NIH HHS K08 CA252161NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA207757NCI NIH HHS R01 CA234162
6 · The paper itself

Abstract

Bladder cancer is an understudied area, particularly in genetically engineered mouse models (GEMMs). Inbred GEMMs with tissue-specific Cre and loxP sites have been the gold standards for conditional or inducible gene targeting. To provide faster and more efficient experimental models, an ex vivo organoid culture system is developed using adenovirus Cre and normal urothelial cells carrying multiple loxP alleles of the tumor suppressors Trp53, Pten, and Rb1. Normal urothelial cells are enzymatically disassociated from four bladders of triple floxed mice (Trp53

Indexed as

AdenoviridaeOrganoidsAnimalsGene DeletionHumansIntegrasesMiceCre recombinaseIntegrases

Identifiers

PMID35604166
PMCPMC9768623
OpenAlexW4228999662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.